Cathepsin D concentration in tumor cytosols improves the accuracy of prognostic evaluation of primary breast cancer

被引：0
|
作者：
Ardavanis, A
Scorilas, A
Amanatidou, A
Gerakini, F
Missitzis, I
Garoufali, A
Pissakas, G
Pateras, C
Apostolikas, N
Rigatos, G
Yiotis, I
机构：
[1] ST SAVVAS CANC HOSP,HORMONAL RECEPTORS LAB,ATHENS 11522,GREECE
[2] ST SAVVAS CANC HOSP,BREAST CLIN,ATHENS 11522,GREECE
[3] ST SAVVAS CANC HOSP,RADIOTHERAPY DEPT 2,ATHENS 11522,GREECE
[4] ST SAVVAS CANC HOSP,PATHOL LAB,ATHENS 11522,GREECE
来源：
ANTICANCER RESEARCH | 1997年 / 17卷 / 2B期
关键词：
breast cancer; prognostic factors; cathepsin D;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
One hundred and seventy three women were followed-up for a median of 62 months after surgery for Stage I-III breast cancer: The concentration of cathepsin D (CD) in tumor cytosols was compared to the standard prognostic factors for the disease and related to relapse free and overall survival and type of relapse. Three groups were identified with different prognostic profile. High CD levels significantly shorten DFS ill both node-negative and node-positive patients; a correlation between high cathepsin D levels and locoregional relapse should also be noted. This marker should be included in the initial evaluation of breast cancer as an indicator of invasiveness.
引用
收藏
页码：1405 / 1409
页数：5
相关论文
共 50 条
  • [21] IMMUNOENZYMATIC ASSAY OF MR 52,000 CATHEPSIN-D IN 182 BREAST-CANCER CYTOSOLS - LOW CORRELATION WITH OTHER PROGNOSTIC PARAMETERS
    MAUDELONDE, T
    KHALAF, S
    GARCIA, M
    FREISS, G
    DUPORTE, J
    BENATIA, M
    ROGIER, H
    PAOLUCCI, F
    SIMONY, J
    PUJOL, H
    PAU, B
    ROCHEFORT, H
    CANCER RESEARCH, 1988, 48 (02) : 462 - 466
  • [22] Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
    Solomayer, EF
    Diel, IJ
    Meyberg, GC
    Gollan, C
    Bode, S
    Wallwiener, D
    Bastert, G
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 49 (02) : 145 - 154
  • [23] Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
    E-F. Solomayer
    I.J. Diel
    G.C. Meyberg
    Ch. Gollan
    S. Bode
    D. Wallwiener
    G. Bastert
    Breast Cancer Research and Treatment, 1998, 49 : 145 - 154
  • [24] Significance of the tumor protease cathepsin D for the biology of breast cancer
    Dian, Darius
    Heublein, Sabine
    Wiest, Irmi
    Barthell, Lisa
    Friese, Klaus
    Jeschke, Udo
    HISTOLOGY AND HISTOPATHOLOGY, 2014, 29 (04) : 433 - 438
  • [25] Prognostic value of TP53 protein accumulation in human primary breast cancer: An analysis by luminometric immunoassay on 1491 tumor cytosols
    Berns, EMJJ
    DeWitte, HH
    Klijn, JGM
    Willman, K
    Look, MP
    MeijervanGelder, ME
    Benraad, TJ
    Foekens, JA
    ANTICANCER RESEARCH, 1997, 17 (4B) : 3003 - 3006
  • [26] CATHEPSIN-D - AN INDEPENDENT PROGNOSTIC FACTOR IN BREAST-CANCER
    ROMAIN, S
    MURACCIOLE, X
    VARETTE, I
    BRESSAC, C
    BRANDONE, H
    MARTIN, PM
    BULLETIN DU CANCER, 1990, 77 (05) : 439 - 447
  • [27] Prognostic significance of cathepsin D and nm23 in breast cancer
    Lombardi, CP
    Scambia, G
    Minelli, S
    Raffaelli, M
    De Crea, C
    Ferrandina, G
    Fagotti, A
    Rossi, S
    Bellantone, R
    10TH INTERNATIONAL CONGRESS ON SENOLOGY - BREAST DISEASES OF THE SENOLOGIC INTERNATIONAL SOCIETY, 1998, : 301 - 305
  • [28] PROGNOSTIC VALUE OF TOTAL CATHEPSIN-D IN BREAST-CANCER
    NAMER, M
    RAMAIOLI, A
    ETIENNE, MC
    FONTANA, X
    LAPALUS, F
    HERY, M
    MILANO, G
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (02) : 178 - 178
  • [29] Keeping data continuous when analyzing the prognostic impact of a tumor marker: an example with cathepsin D in breast cancer
    Bossard, N
    Descotes, F
    Bremond, AG
    Bobin, Y
    De Saint Hilarie, P
    Golfier, F
    Awada, A
    Mathevet, PM
    Berrerd, L
    Barbier, Y
    Estève, J
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 (01) : 47 - 59
  • [30] Keeping Data Continuous when Analyzing the Prognostic Impact of a Tumor Marker: An Example with Cathepsin D in Breast Cancer
    N. Bossard
    F. Descotes
    A.G. Bremond
    Y. Bobin
    P. De Saint Hilaire
    F. Golfier
    A. Awada
    P.M. Mathevet
    L. Berrerd
    Y. Barbier
    J. Estève
    Breast Cancer Research and Treatment, 2003, 82 : 47 - 59
12345